This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spinks, N. R. Articles by O'Neill, C. Search for Related Content PubMed Articles by Spinks, N. R. Articles by O'Neill, C.

Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos

Summary. Inhibitors of platelet activation, alprazolam, iloprost and SRI 63-441, were used to demonstrate the necessity of embryo-derived platelet-activating factor (PAF) activity for the establishment of pregnancy in mice. In a splenectomized mouse bioassay 6 µg alprazolam inhibited, for 3 h, the thrombocytopenia induced by 0·1 µg PAF: 4 µg iloprost and 0·5 µg SRI 63-441 were effective for 6 and 12 h respectively. The administration of 2 µg iloprost/30 g body weight on Days 1 and 4 of pregnancy and twice daily on Days 2 and 3 caused a 50% reduction (P < 0·0005) in the number of implantation sites in the uterus at Day 8 of pregnancy, without affecting (P > 0·05) the number of corpora lutea. A similar reduction in the number of implantation sites was achieved with 20 µg SRI 63-441/30 g body weight/day. The reduction in implantation rate was evident on Day 5 of pregnancy by visualizing the implantation sites with pontamine sky blue. SRI 63-441 had no effect on peripheral blood progesterone concentrations from Day 1 to Day 9 of pregnancy, and did not appear to inhibit implantation by blocking the preimplantation surge of oestradiol. The number and morphology of blastocysts flushed from the uterus of Day 4 inhibitor-treated mice was not different (P > 0·05) from the controls. The cleavage rate and morphology of embryos cultured from the 2-cell to blastocyst stage in media containing SRI 63-441 or iloprost (10 µg/ml) were normal, precluding a gross toxic effect. Simultaneous administration of 1 µg PAF-acether to treated animals re-established pregnancy rates to levels not significantly different (P > 0·05) from the controls.

Keywords: mouse; implantation; PAF; iloprost; alprazolam; SRI 63-441

This article has been cited by other articles:

				C. O'Neill The role of paf in embryo physiology Hum. Reprod. Update, May 1, 2005; 11(3): 215 - 228. [Abstract] [Full Text] [PDF]

				D. P. Lu, V. Chandrakanthan, A. Cahana, S. Ishii, and C. O'Neill Trophic signals acting via phosphatidylinositol-3 kinase are required for normal pre-implantation mouse embryo development J. Cell Sci., March 15, 2004; 117(8): 1567 - 1576. [Abstract] [Full Text] [PDF]

				W.E. Roudebush, J.D. Wininger, A.E. Jones, G. Wright, A.A. Toledo, H.I. Kort, J.B. Massey, and D.B. Shapiro Embryonic platelet-activating factor: an indicator of embryo viability Hum. Reprod., May 1, 2002; 17(5): 1306 - 1310. [Abstract] [Full Text] [PDF]

				T. Stojanov and C. O'Neill Ontogeny of Expression of a Receptor for Platelet-Activating Factor in Mouse Preimplantation Embryos and the Effects of Fertilization and Culture In Vitro on Its Expression Biol Reprod, March 1, 1999; 60(3): 674 - 682. [Abstract] [Full Text]